Jonas Mattsson
0000-0002-2163-6644
Karolinska Institute
206 papers found
Refreshing results…
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
Tumor reduction surgery followed by allogeneic stem cell transplantation. A treatment for disseminated gastrointestinal cancer?
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT)
Lower incidence of bacteremias using allogeneic peripheral blood stem cells compared to bone marrow.
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation
Unrelated donor stem cell transplantation after autologous transplantation: Experience of a single center
Mixed chimerism and minimal residual disease in patients with CLL - Is eradication below PCR detectable MRD necessary for long term survival after bone marrow transplantation?
Mixed chimerism in the B-cell lineage is correlated to relapse in BMT recipients with pre-B-cell ALL.
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: A retrospective single centre analysis
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination
Post-BMT monitoring of 40 patients by PCR-amplification of immunomagnetically immobilized cells to detect minimal residual disease.
A rapid technique for post-BMT monitoring of patients with acute leukemia by PCR amplification of immunomagnetically immobilized cells to detect minimal residual disease.
A prospective randomized trial giving G-CSF at different times after unrelated BMT.
Low incidence of acute graft-versus-host disease, using unrelated HLA-A, -B, and -DR identical donors and conditioning, including anti-T-cell antibodies.
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation
Missing publications? Search for publications with a matching author name.